Dr. Eric Nilles | Immunoepidemiology | Best Researcher Award

Assoc. Prof. Dr. Eric Nilles | Immunoepidemiology | Best Researcher Award

Harvard Medical School | United States.

Author Profile

Scopus Profile

Orcid Profile

Scholar Profile

🎓Education

Dr. Eric J. Nilles holds a B.S. in History (1996) and an M.D. in Medicine (2000) from the University of Wisconsin-Madison. He further specialized in Tropical Medicine and International Health with an M.Sc. from the London School of Hygiene & Tropical Medicine in 2007, focusing on global health challenges.

💼Professional Experience

Dr. Nilles has extensive global healthcare experience, including roles as Attending Physician in emergency medicine at Brigham and Women’s Hospital, Boston, and senior consultant positions in the U.A.E. He has worked with Médecins Sans Frontières in Sudan, Chad, Haiti, and the Democratic Republic of Congo, managing infectious disease outbreaks and humanitarian crises. At the World Health Organization (WHO), he served as Team Leader for Emerging Disease Surveillance in the Pacific region, driving epidemic preparedness and response.

🔬Technical Skills

Dr. Nilles is proficient in epidemic preparedness, health systems strengthening, and humanitarian crisis response. His expertise extends to designing and implementing surveillance systems and response mechanisms for emerging infectious diseases.

🔬Research Interests

Dr. Nilles is passionate about infectious disease control, epidemic preparedness, and health system resilience in humanitarian settings. He actively explores the intersection of global health security and emergency response systems to combat emerging health threats.

📚Academic Contributions 

Dr. Nilles has held esteemed academic appointments, currently serving as an Associate Professor of Emergency Medicine at Harvard Medical School. He also holds a core faculty position at the Harvard Humanitarian Initiative, where he directs the Infectious Diseases and Epidemics Program. His teaching spans courses at the Harvard T.H. Chan School of Public Health and mentoring future clinicians through Harvard Medical School programs.

🏆Awards & Recognition

Dr. Nilles has received numerous accolades, including the Humanitarian Service Award (2020) from the Global Emergency Medicine Academy and the Research and Scholarship Award (2023) from the Brigham and Women’s Hospital Department of Emergency Medicine. His humanitarian efforts earned him the Friendship Award (2016) from Fiji’s Centres for Communicable Disease Control.

📘Teaching Experience

Dr. Nilles has contributed to education through innovative teaching methods, such as simulation exercises and specialized courses on post-disaster epidemics, humanitarian health programs, and diseases of the displaced. He engages with students at various levels, from medical undergraduates to MPH professionals and humanitarians worldwide.

Dr. Eric J. Nilles exemplifies dedication to clinical excellence, global health, and education, making a lasting impact on both local and international health landscapes.

📑Notable Publications 

“Seroepidemiology of human leptospirosis in the Dominican Republic: A multistage cluster survey, 2021”

Authors: Nilles, E.J., Paulino, C.T., Galloway, R., Kucharski, A., Lau, C.L.
Publication Year: 2024
Journal: PLoS Neglected Tropical Diseases

“Chikungunya Outbreak Risks after the 2014 Outbreak, Dominican Republic”

Authors: Loevinsohn, G., Then Paulino, C., Spring, J., Lau, C.L., Nilles, E.J.
Publication Year: 2024
Journal: Emerging Infectious Diseases

“Convergence of SARS-CoV-2 spike antibody levels to a population immune setpoint”

Authors: Nilles, E.J., Roberts, K., de St Aubin, M., Lau, C.L., Kucharski, A.
Publication Year: 2024
Journal: eBioMedicine

“Effects of mobility, immunity and vaccination on SARS-CoV-2 transmission in the Dominican Republic: a modelling study”

Authors: Finch, E., Nilles, E.J., Paulino, C.T., Lowe, R., Kucharski, A.J.
Publication Year: 2024
Journal: The Lancet Regional Health – Americas

“Hand hygiene perceptions, preferences, and practices among hospital staff in the Dominican Republic in the context of COVID-19: a qualitative study”

Authors: Craig, C.E., Schnorr, C.D., Then Paulino, C.J., Lozier, M.J., Nilles, E.J.
Publication Year: 2024
Journal: Infection Prevention in Practice

“Using Regional Sero-Epidemiology SARS-CoV-2 Anti-S Antibodies in the Dominican Republic to Inform Targeted Public Health Response”

Authors: Mario Martin, B., Cadavid Restrepo, A., Mayfield, H.J., Nilles, E.J., Lau, C.L.
Publication Year: 2023
Journal: Tropical Medicine and Infectious Disease

“Longitudinal changes in hand hygiene adherence among healthcare workers during the COVID-19 pandemic, Dominican Republic”

Authors: Daniel Schnorr, C., Roberts, K.W., Payano, E.C., Duke, W., Nilles, E.
Publication Year: 2024
Journal: PLOS Water

Prof. Lang Bu | Immunity | Best Researcher Award

Prof. Lang Bu | Immunity | Best Researcher Award

Sun Yat-sen University | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Prof. Lang Bu’s academic journey began with a focus on innate immunity, virus infections, and liver cancer, laying the foundation for groundbreaking research in signal transduction and tumor microenvironment. His passion for molecular biology and protein modifications has driven his career in precision medicine. His early education in these areas led him to specialize in innovative therapeutic strategies for combating cancer and viral diseases.

💼PROFESSIONAL ENDEAVORS

Prof. Bu currently serves as an Associate Researcher at the Institute of Precision Medicine in Sun Yat-sen University, where he contributes to cutting-edge research on innate immunity and viral infection. His professional experience spans consultancy projects and leadership in high-impact research. His work extends to industry collaborations, underscoring his connection between academic research and practical applications.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON IMMUNITY

Prof. Bu’s research has significantly contributed to the understanding of tumor immunology, particularly focusing on innate immunity, viral infections, and liver cancer. He utilizes advanced techniques to explore signal transduction pathways and immune response mechanisms. His work in post-translational modifications and DNA sequencing has paved the way for personalized treatments, offering insights into innovative therapeutic approaches for cancer and infectious diseases.

🌍IMPACT AND INFLUENCE

Prof. Bu’s research has influenced the fields of viral immunity, tumor biology, and cancer immunotherapy. With significant contributions to global health through published works in SCI and Scopus journals, his influence extends into clinical and global health solutions. Prof. Bu’s findings aim to address critical health issues, particularly in liver cancer and virus-related diseases, ensuring impactful global influence.

📚ACADEMIC CITES

Prof. Bu has a citation index of PMID: 39255795, with 18 published journals in SCI and Scopus-indexed journals. His work has established him as a respected researcher in the areas of innate immunity and virus infection, positioning him as a key figure in advancing the scientific community’s understanding of these critical areas.

🏆RESEARCH GRANTS AND FUNDING

Prof. Bu has successfully secured research funding to support his work in tumor microenvironment and genomic technologies. His ability to attract substantial research grants has enabled further exploration into personalized cancer therapies and advanced immunotherapies, advancing the application of precision medicine.

🛡️LEGACY AND FUTURE CONTRIBUTIONS

Prof. Bu’s legacy is grounded in advancing immune-based therapies and enhancing our understanding of tumor immunity. His ongoing research into innate immunity and viral infection mechanisms is expected to contribute to groundbreaking therapeutic strategies for cancer and infectious diseases.

📑NOTABLE PUBLICATIONS

“Targeting APT2 improves MAVS palmitoylation and antiviral innate immunity”

Authors: Bu, L., Wang, H., Zhang, S., Cheng, C., Guo, J.
Publication Year: 2024
Journal: Molecular Cell
Citations: 2

“High-fat diet promotes liver tumorigenesis via palmitoylation and activation of AKT”

Authors: Bu, L., Zhang, Z., Chen, J., Kuang, M., Guo, J.
Publication Year: 2024
Journal: Gut
Citations: 19

“Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis”

Authors: Gao, B., Wu, X., Bu, L., Xie, W., Guo, J.
Publication Year: 2024
Journal: Science Advances
Citations: 3

“AMPK phosphorylates and stabilises copper transporter 1 to synergise metformin and copper chelator for breast cancer therapy”

Authors: Zhang, X., Jiang, Q., Su, Y., Xie, W., Guo, J.
Publication Year: 2023
Journal: British Journal of Cancer
Citations: 9

“AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis”

Authors: Sun, Z., Jiang, Q., Gao, B., Li, J., Guo, J.
Publication Year: 2023
Journal: Cancer Research
Citations: 11